Hemodynamic oxygenator exchange-related effects during veno-venous extracorporeal membrane oxygenation for the treatment of acute SARS-CoV-2 respiratory distress syndrome
Few patients with coronavirus disease 2019–associated severe acute respiratory distress syndrome (ARDS) require veno-venous extracorporeal membrane oxygenation (VV-ECMO). Prolonged VV-ECMO support necessitates repeated oxygenator replacement, increasing the risk for complications. Transient hypoxemi...
Gespeichert in:
| Veröffentlicht in: | Perfusion 2023-03, Vol.38 (2), p.425-427 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 427 |
|---|---|
| container_issue | 2 |
| container_start_page | 425 |
| container_title | Perfusion |
| container_volume | 38 |
| creator | Colombier, Sébastien Gross, Adrien Schneider, Antoine Tozzi, Piergiorgio Ltaief, Zied Verdugo-Marchese, Mario Kirsch, Matthias Niclauss, Lars |
| description | Few patients with coronavirus disease 2019–associated severe acute respiratory distress syndrome (ARDS) require veno-venous extracorporeal membrane oxygenation (VV-ECMO). Prolonged VV-ECMO support necessitates repeated oxygenator replacement, increasing the risk for complications. Transient hypoxemia, induced by VV-ECMO stop needed for this procedure, may induce transient myocardial ischemia and acutely declining cardiac output in critically ill patients without residual pulmonary function. This is amplified by additional activation of the sympathetic nervous system (tachycardia, pulmonary vasoconstriction, and increased systemic vascular resistance). Immediate reinjection of the priming solution of the new circuit and induced acute iatrogenic anemia are other potentially reinforcing factors. The case of a critically ill patient presented here provides an instructive illustration of the hemodynamic relationships occurring during VV-ECMO support membrane oxygenator exchange. |
| doi_str_mv | 10.1177/02676591211056564 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9932605</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_02676591211056564</sage_id><sourcerecordid>2636143885</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-47481a9b5a81b544d19b42e3ebf844e2d32c05934c8edffad6085e4f5c4f9de83</originalsourceid><addsrcrecordid>eNp1ks1u1DAQgCMEokvhAbggS1y4pNiO7cQXpGpVKFIlJAqIW-TY42yqxF5sp2peiafE0ZblT1zsw3zzeWY8RfGc4DNC6vo1pqIWXBJKCOaCC_ag2BBW1yUh5OvDYrPGyxU4KZ7EeIMxZoxVj4uTilPGpaSb4vslTN4sTk2DRv5u6cGp5AOCO71TrocywKgSGATWgk4RmTkMrke34Hy5HnPMbApK-7D3AdSIJpi6oBwcdYN3yGZn2gFKGUkTuIS8RUrPCdD1-cfrcuu_lBQFiPshrAUsyAwxwzGiuDgT_ARPi0dWjRGe3d-nxee3F5-2l-XVh3fvt-dXpWakSSWrWUOU7LhqSMcZM0R2jEIFnW0YA2oqqjGXFdMNGGuVEbjhwCzXzEoDTXVavDl493M3gdG52KDGdh-GSYWl9Wpo_4y4Ydf2_raVsqIC8yx4dS8I_tsMMbXTEDWMYx5KnldLRSUIq5pmRV_-hd74ObjcXkvrWkghWI0zRQ6UDj7GAPZYDMHtugntP5uQc1783sUx4-fXZ-DsAETVw69n_2_8ASZRwV8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2776966470</pqid></control><display><type>article</type><title>Hemodynamic oxygenator exchange-related effects during veno-venous extracorporeal membrane oxygenation for the treatment of acute SARS-CoV-2 respiratory distress syndrome</title><source>MEDLINE</source><source>SAGE Complete</source><creator>Colombier, Sébastien ; Gross, Adrien ; Schneider, Antoine ; Tozzi, Piergiorgio ; Ltaief, Zied ; Verdugo-Marchese, Mario ; Kirsch, Matthias ; Niclauss, Lars</creator><creatorcontrib>Colombier, Sébastien ; Gross, Adrien ; Schneider, Antoine ; Tozzi, Piergiorgio ; Ltaief, Zied ; Verdugo-Marchese, Mario ; Kirsch, Matthias ; Niclauss, Lars</creatorcontrib><description>Few patients with coronavirus disease 2019–associated severe acute respiratory distress syndrome (ARDS) require veno-venous extracorporeal membrane oxygenation (VV-ECMO). Prolonged VV-ECMO support necessitates repeated oxygenator replacement, increasing the risk for complications. Transient hypoxemia, induced by VV-ECMO stop needed for this procedure, may induce transient myocardial ischemia and acutely declining cardiac output in critically ill patients without residual pulmonary function. This is amplified by additional activation of the sympathetic nervous system (tachycardia, pulmonary vasoconstriction, and increased systemic vascular resistance). Immediate reinjection of the priming solution of the new circuit and induced acute iatrogenic anemia are other potentially reinforcing factors. The case of a critically ill patient presented here provides an instructive illustration of the hemodynamic relationships occurring during VV-ECMO support membrane oxygenator exchange.</description><identifier>ISSN: 0267-6591</identifier><identifier>EISSN: 1477-111X</identifier><identifier>DOI: 10.1177/02676591211056564</identifier><identifier>PMID: 35245992</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Anemia ; Cardiac output ; Case Reports ; Circuits ; Complications ; Coronaviruses ; COVID-19 ; COVID-19 - therapy ; Critical Illness ; Extracorporeal Membrane Oxygenation - adverse effects ; Extracorporeal Membrane Oxygenation - methods ; Hemodynamics ; Humans ; Hypoxemia ; Ischemia ; Membranes ; Myocardial ischemia ; Oxygenation ; Oxygenators ; Priming ; Pulmonary functions ; Reinjection ; Respiratory distress syndrome ; Respiratory Distress Syndrome - etiology ; Respiratory Distress Syndrome - therapy ; Respiratory function ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Sympathetic nervous system ; Tachycardia ; Vasoconstriction ; Viral diseases</subject><ispartof>Perfusion, 2023-03, Vol.38 (2), p.425-427</ispartof><rights>The Author(s) 2022</rights><rights>The Author(s) 2022 2022 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c418t-47481a9b5a81b544d19b42e3ebf844e2d32c05934c8edffad6085e4f5c4f9de83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/02676591211056564$$EPDF$$P50$$Gsage$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/02676591211056564$$EHTML$$P50$$Gsage$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35245992$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Colombier, Sébastien</creatorcontrib><creatorcontrib>Gross, Adrien</creatorcontrib><creatorcontrib>Schneider, Antoine</creatorcontrib><creatorcontrib>Tozzi, Piergiorgio</creatorcontrib><creatorcontrib>Ltaief, Zied</creatorcontrib><creatorcontrib>Verdugo-Marchese, Mario</creatorcontrib><creatorcontrib>Kirsch, Matthias</creatorcontrib><creatorcontrib>Niclauss, Lars</creatorcontrib><title>Hemodynamic oxygenator exchange-related effects during veno-venous extracorporeal membrane oxygenation for the treatment of acute SARS-CoV-2 respiratory distress syndrome</title><title>Perfusion</title><addtitle>Perfusion</addtitle><description>Few patients with coronavirus disease 2019–associated severe acute respiratory distress syndrome (ARDS) require veno-venous extracorporeal membrane oxygenation (VV-ECMO). Prolonged VV-ECMO support necessitates repeated oxygenator replacement, increasing the risk for complications. Transient hypoxemia, induced by VV-ECMO stop needed for this procedure, may induce transient myocardial ischemia and acutely declining cardiac output in critically ill patients without residual pulmonary function. This is amplified by additional activation of the sympathetic nervous system (tachycardia, pulmonary vasoconstriction, and increased systemic vascular resistance). Immediate reinjection of the priming solution of the new circuit and induced acute iatrogenic anemia are other potentially reinforcing factors. The case of a critically ill patient presented here provides an instructive illustration of the hemodynamic relationships occurring during VV-ECMO support membrane oxygenator exchange.</description><subject>Anemia</subject><subject>Cardiac output</subject><subject>Case Reports</subject><subject>Circuits</subject><subject>Complications</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - therapy</subject><subject>Critical Illness</subject><subject>Extracorporeal Membrane Oxygenation - adverse effects</subject><subject>Extracorporeal Membrane Oxygenation - methods</subject><subject>Hemodynamics</subject><subject>Humans</subject><subject>Hypoxemia</subject><subject>Ischemia</subject><subject>Membranes</subject><subject>Myocardial ischemia</subject><subject>Oxygenation</subject><subject>Oxygenators</subject><subject>Priming</subject><subject>Pulmonary functions</subject><subject>Reinjection</subject><subject>Respiratory distress syndrome</subject><subject>Respiratory Distress Syndrome - etiology</subject><subject>Respiratory Distress Syndrome - therapy</subject><subject>Respiratory function</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Sympathetic nervous system</subject><subject>Tachycardia</subject><subject>Vasoconstriction</subject><subject>Viral diseases</subject><issn>0267-6591</issn><issn>1477-111X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>EIF</sourceid><recordid>eNp1ks1u1DAQgCMEokvhAbggS1y4pNiO7cQXpGpVKFIlJAqIW-TY42yqxF5sp2peiafE0ZblT1zsw3zzeWY8RfGc4DNC6vo1pqIWXBJKCOaCC_ag2BBW1yUh5OvDYrPGyxU4KZ7EeIMxZoxVj4uTilPGpaSb4vslTN4sTk2DRv5u6cGp5AOCO71TrocywKgSGATWgk4RmTkMrke34Hy5HnPMbApK-7D3AdSIJpi6oBwcdYN3yGZn2gFKGUkTuIS8RUrPCdD1-cfrcuu_lBQFiPshrAUsyAwxwzGiuDgT_ARPi0dWjRGe3d-nxee3F5-2l-XVh3fvt-dXpWakSSWrWUOU7LhqSMcZM0R2jEIFnW0YA2oqqjGXFdMNGGuVEbjhwCzXzEoDTXVavDl493M3gdG52KDGdh-GSYWl9Wpo_4y4Ydf2_raVsqIC8yx4dS8I_tsMMbXTEDWMYx5KnldLRSUIq5pmRV_-hd74ObjcXkvrWkghWI0zRQ6UDj7GAPZYDMHtugntP5uQc1783sUx4-fXZ-DsAETVw69n_2_8ASZRwV8</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Colombier, Sébastien</creator><creator>Gross, Adrien</creator><creator>Schneider, Antoine</creator><creator>Tozzi, Piergiorgio</creator><creator>Ltaief, Zied</creator><creator>Verdugo-Marchese, Mario</creator><creator>Kirsch, Matthias</creator><creator>Niclauss, Lars</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230301</creationdate><title>Hemodynamic oxygenator exchange-related effects during veno-venous extracorporeal membrane oxygenation for the treatment of acute SARS-CoV-2 respiratory distress syndrome</title><author>Colombier, Sébastien ; Gross, Adrien ; Schneider, Antoine ; Tozzi, Piergiorgio ; Ltaief, Zied ; Verdugo-Marchese, Mario ; Kirsch, Matthias ; Niclauss, Lars</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-47481a9b5a81b544d19b42e3ebf844e2d32c05934c8edffad6085e4f5c4f9de83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anemia</topic><topic>Cardiac output</topic><topic>Case Reports</topic><topic>Circuits</topic><topic>Complications</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - therapy</topic><topic>Critical Illness</topic><topic>Extracorporeal Membrane Oxygenation - adverse effects</topic><topic>Extracorporeal Membrane Oxygenation - methods</topic><topic>Hemodynamics</topic><topic>Humans</topic><topic>Hypoxemia</topic><topic>Ischemia</topic><topic>Membranes</topic><topic>Myocardial ischemia</topic><topic>Oxygenation</topic><topic>Oxygenators</topic><topic>Priming</topic><topic>Pulmonary functions</topic><topic>Reinjection</topic><topic>Respiratory distress syndrome</topic><topic>Respiratory Distress Syndrome - etiology</topic><topic>Respiratory Distress Syndrome - therapy</topic><topic>Respiratory function</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Sympathetic nervous system</topic><topic>Tachycardia</topic><topic>Vasoconstriction</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Colombier, Sébastien</creatorcontrib><creatorcontrib>Gross, Adrien</creatorcontrib><creatorcontrib>Schneider, Antoine</creatorcontrib><creatorcontrib>Tozzi, Piergiorgio</creatorcontrib><creatorcontrib>Ltaief, Zied</creatorcontrib><creatorcontrib>Verdugo-Marchese, Mario</creatorcontrib><creatorcontrib>Kirsch, Matthias</creatorcontrib><creatorcontrib>Niclauss, Lars</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Perfusion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Colombier, Sébastien</au><au>Gross, Adrien</au><au>Schneider, Antoine</au><au>Tozzi, Piergiorgio</au><au>Ltaief, Zied</au><au>Verdugo-Marchese, Mario</au><au>Kirsch, Matthias</au><au>Niclauss, Lars</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemodynamic oxygenator exchange-related effects during veno-venous extracorporeal membrane oxygenation for the treatment of acute SARS-CoV-2 respiratory distress syndrome</atitle><jtitle>Perfusion</jtitle><addtitle>Perfusion</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>38</volume><issue>2</issue><spage>425</spage><epage>427</epage><pages>425-427</pages><issn>0267-6591</issn><eissn>1477-111X</eissn><abstract>Few patients with coronavirus disease 2019–associated severe acute respiratory distress syndrome (ARDS) require veno-venous extracorporeal membrane oxygenation (VV-ECMO). Prolonged VV-ECMO support necessitates repeated oxygenator replacement, increasing the risk for complications. Transient hypoxemia, induced by VV-ECMO stop needed for this procedure, may induce transient myocardial ischemia and acutely declining cardiac output in critically ill patients without residual pulmonary function. This is amplified by additional activation of the sympathetic nervous system (tachycardia, pulmonary vasoconstriction, and increased systemic vascular resistance). Immediate reinjection of the priming solution of the new circuit and induced acute iatrogenic anemia are other potentially reinforcing factors. The case of a critically ill patient presented here provides an instructive illustration of the hemodynamic relationships occurring during VV-ECMO support membrane oxygenator exchange.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>35245992</pmid><doi>10.1177/02676591211056564</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0267-6591 |
| ispartof | Perfusion, 2023-03, Vol.38 (2), p.425-427 |
| issn | 0267-6591 1477-111X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9932605 |
| source | MEDLINE; SAGE Complete |
| subjects | Anemia Cardiac output Case Reports Circuits Complications Coronaviruses COVID-19 COVID-19 - therapy Critical Illness Extracorporeal Membrane Oxygenation - adverse effects Extracorporeal Membrane Oxygenation - methods Hemodynamics Humans Hypoxemia Ischemia Membranes Myocardial ischemia Oxygenation Oxygenators Priming Pulmonary functions Reinjection Respiratory distress syndrome Respiratory Distress Syndrome - etiology Respiratory Distress Syndrome - therapy Respiratory function SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Sympathetic nervous system Tachycardia Vasoconstriction Viral diseases |
| title | Hemodynamic oxygenator exchange-related effects during veno-venous extracorporeal membrane oxygenation for the treatment of acute SARS-CoV-2 respiratory distress syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T14%3A45%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemodynamic%20oxygenator%20exchange-related%20effects%20during%20veno-venous%20extracorporeal%20membrane%20oxygenation%20for%20the%20treatment%20of%20acute%20SARS-CoV-2%20respiratory%20distress%20syndrome&rft.jtitle=Perfusion&rft.au=Colombier,%20S%C3%A9bastien&rft.date=2023-03-01&rft.volume=38&rft.issue=2&rft.spage=425&rft.epage=427&rft.pages=425-427&rft.issn=0267-6591&rft.eissn=1477-111X&rft_id=info:doi/10.1177/02676591211056564&rft_dat=%3Cproquest_pubme%3E2636143885%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2776966470&rft_id=info:pmid/35245992&rft_sage_id=10.1177_02676591211056564&rfr_iscdi=true |